116 related articles for article (PubMed ID: 38917380)
1. Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis.
Marastoni D; Turano E; Tamanti A; Colato E; Pisani AI; Scartezzini A; Carotenuto S; Mazziotti V; Camera V; Anni D; Ziccardi S; Guandalini M; Pizzini FB; Virla F; Mariotti R; Magliozzi R; Bonetti B; Steinman L; Calabrese M
Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200265. PubMed ID: 38917380
[TBL] [Abstract][Full Text] [Related]
2. CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis.
Marastoni D; Pisani AI; Schiavi G; Mazziotti V; Castellaro M; Tamanti A; Bosello F; Crescenzo F; Ricciardi GK; Montemezzi S; Pizzini FB; Calabrese M
Ther Adv Neurol Disord; 2022; 15():17562864221092124. PubMed ID: 35755969
[TBL] [Abstract][Full Text] [Related]
3. The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity.
Magliozzi R; Scalfari A; Pisani AI; Ziccardi S; Marastoni D; Pizzini FB; Bajrami A; Tamanti A; Guandalini M; Bonomi S; Rossi S; Mazziotti V; Castellaro M; Montemezzi S; Rasia S; Capra R; Pitteri M; Romualdi C; Reynolds R; Calabrese M
Ann Neurol; 2020 Sep; 88(3):562-573. PubMed ID: 32418239
[TBL] [Abstract][Full Text] [Related]
4. CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis.
Marastoni D; Magliozzi R; Bolzan A; Pisani AI; Rossi S; Crescenzo F; Montemezzi S; Pizzini FB; Calabrese M
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34588298
[TBL] [Abstract][Full Text] [Related]
5. CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis.
Marastoni D; Foschi M; Eccher C; Crescenzo F; Mazziotti V; Tamanti A; Bajrami A; Camera V; Ziccardi S; Guandalini M; Bosello F; Anni D; Virla F; Turano E; Romoli M; Mariotti R; Pizzini FB; Bonetti B; Calabrese M
Front Immunol; 2024; 15():1343892. PubMed ID: 38404586
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.
De Fino C; Lucchini M; Lucchetti D; Nociti V; Losavio FA; Bianco A; Colella F; Ricciardi-Tenore C; Sgambato A; Mirabella M
Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal patterns of cortical thinning in multiple sclerosis.
Tsagkas C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Magon S
Hum Brain Mapp; 2020 Jun; 41(8):2198-2215. PubMed ID: 32067281
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study.
Hidalgo de la Cruz M; Valsasina P; Gobbi C; Gallo A; Zecca C; Bisecco A; Tedeschi G; Filippi M; Rocca MA
Mult Scler; 2021 May; 27(6):827-840. PubMed ID: 32662748
[TBL] [Abstract][Full Text] [Related]
10. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation.
Magliozzi R; Pezzini F; Pucci M; Rossi S; Facchiano F; Marastoni D; Montagnana M; Lippi G; Reynolds R; Calabrese M
Cells; 2021 Jul; 10(7):. PubMed ID: 34359880
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis.
Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808
[TBL] [Abstract][Full Text] [Related]
12. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
[TBL] [Abstract][Full Text] [Related]
14. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
[TBL] [Abstract][Full Text] [Related]
15. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.
Farina G; Magliozzi R; Pitteri M; Reynolds R; Rossi S; Gajofatto A; Benedetti MD; Facchiano F; Monaco S; Calabrese M
J Neuroinflammation; 2017 Feb; 14(1):40. PubMed ID: 28222766
[TBL] [Abstract][Full Text] [Related]
16. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study.
Calabrese M; Grossi P; Favaretto A; Romualdi C; Atzori M; Rinaldi F; Perini P; Saladini M; Gallo P
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):49-54. PubMed ID: 21890577
[TBL] [Abstract][Full Text] [Related]
17. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
[TBL] [Abstract][Full Text] [Related]
18. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis.
Hradilek P; Revendova KZ; Horakova J; Bunganic R; Pelisek O; Zeman D; Hanzlikova P; Kusnierova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):30-35. PubMed ID: 36695545
[TBL] [Abstract][Full Text] [Related]
20. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
Zivadinov R; Horakova D; Bergsland N; Hagemeier J; Ramasamy DP; Uher T; Vaneckova M; Havrdova E; Dwyer MG
AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
